secwatch / observer
8-K filed January 4, 2022, 6:59 PM ET ticker OHI CIK 0000888491
leadership confidence high sentiment neutral materiality 0.30

Omega Healthcare: Chief Corporate Development Officer Steve Insoft to depart Jan 1, 2022

OMEGA HEALTHCARE INVESTORS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven J. Insoft

Chief Corporate Development Officer
OHI · OMEGA HEALTHCARE INVESTORS INC
Effective
2022-01-01
Filed
January 4, 2022, 6:59 PM ET
On December 31, 2021, Omega Healthcare Investors, Inc. (the “Company”) and Mr. Steven J. Insoft, the Company’s Chief Corporate Development Officer, mutually agreed that Mr. Insoft’s employment with the Company will terminate effective January 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven J. Insoft was terminated as Chief Corporate Development Officer at OMEGA HEALTHCARE INVESTORS INC.

Action
terminated
Role
Chief Corporate Development Officer
Exact text from the filing
On December 31, 2021, Omega Healthcare Investors, Inc. (the “Company”) and Mr. Steven J. Insoft, the Company’s Chief Corporate Development Officer, mutually agreed that Mr. Insoft’s employment with the Company will terminate effective January 1, 2022.
View on SEC.gov

OMEGA HEALTHCARE INVESTORS INC filing history →

Source: SEC EDGAR
accession 0001104659-22-000711
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.